Distinct plasma-mediated inflammatory responses, as defined by our laboratory assay and changes in WCC and CRP from baseline during the first week of hospitalization, were associated with organ dysfunction and death in albumin-treated advanced liver disease patients. This evidence concerns the gene ALB and liver disorder.